BD

Bhaskar Dey

Active Director Director DIN 08945358
DIN 08945358 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Bhaskar Dey

Data last updated:

Bhaskar Dey is a Director at Natcure Biotech Private Limited (since 2020). The company operates in Pharma. Natcure Biotech Private Limited reported revenue of ₹9.09 Cr (FY 2024).

DIN 08945358
Primary Designation Director
Industry Pharma
First Appointment 19 Oct 2020
Oldest Company Age 7 yrs
Largest company Natcure Biotech Private Limited · ₹9.09 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Natcure Biotech Private Limited U24110CT2019PTC009360
Director19 Oct 20202019₹9.09 Cr (FY 2024)Active

Board colleagues of Bhaskar Dey

Directorship timeline

Open interactive timeline →
Natcure Biotech Private Limited
Premium access

Shareholding and investment profile for Bhaskar Dey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhaskar Dey

Bhaskar Dey currently holds 1 directorship: Natcure Biotech Private Limited (Director, since 19 Oct 2020, revenue ₹9.09 Cr (FY 2024)).

Bhaskar Dey was first appointed on 19 Oct 2020 as Director at Natcure Biotech Private Limited.

The current boards of Bhaskar Dey's companies include Anil Kumar Singh (Natcure Biotech Private Limited), Piyush Agrawal (Natcure Biotech Private Limited), Shyam Sundar Agrawal (Natcure Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available